Navigating Challenges in CAR T-Cell Therapy

This chapter examines the complexities associated with CAR T-cell therapy in patients who do not respond adequately, discussing bispecific antibodies as a potential alternative. It highlights significant clinical outcomes from recent trials, emphasizing the benefits of early administration and the challenges of managing side effects. The chapter also explores innovative approaches in targeting lymphoma and the need for personalized treatment strategies based on patient health and response.